TNF inhibitor
Date |
Type | Title | Save |
|---|---|---|---|
| 09 May 2019 | Social | Analysis of claims data compared hospitalized infection rates among 11,248 matched pairs of new initiators of abatacept or TNF inhibitors. Serious hosp infections were significantly lower in ABA vs infliximab (HR 0.63; 0.47-0.85), but similar to ETN & ADA https://t.co/JhXlC7p1A7 | |
| 29 Mar 2019 | News | FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis | |
| 13 Mar 2019 | News | Lower TNF Inhibitor Persistence in Spondylitis | |
| 22 Feb 2019 | News | The Risk of Tuberculosis with TNF Inhibitors | |
| 11 Feb 2019 | ACR Video | QD Clinic - Breast Cancer & a TNF Inhibitor | |
| 06 Feb 2019 | Social | The EMAs CHMP has issued a eceived a positive opinion for 2 TNF inhibitor biosimilars: Idacio (adalimumab) and Kromeya (adalimumab). For the treatment of select inflammatory and autoimmune disorders https://t.co/lz7EvtTcTB | |
| 24 Jan 2019 | Social | Using FMF-KI knockout mice (high TNF levels) researchers find TNF signaling drives pyrin & inflammasome activation; TNF is a critical modulator of pyrin of pyrin-inflammasomopathies like FMF. This is why TNF inhib sometimes work in inflammasomopathies. https://t.co/0EvuTI57tn | |
| 19 Dec 2018 | Social | Study from the UK BSRBR registry shows 34 cancers & 41 deaths in 709 pts. Risk of CA w/ TNFi was not increased (SIR 0.94; 95% CI 0.65,1.34) (but for 2 fold incr risk of nonmelanoma skin CA) & all-cause mortality rate was increased (SMR 1.56) from CV events https://t.co/6HSnw5SOF8 | |
| 25 Oct 2018 | Social | RT @WIRheum: MTB screening in patients on TNFi When to re-screen? Neg to pos conversion discovered in a small number of cases Often in p… | |
| 25 Oct 2018 | Social | RT @NicoleBitencou5: Use of antiTNF in childhood does NOT appear to increase risk of malignancy in adults according to Medicare claims data… | |
| 23 Oct 2018 | ACR Video | Dr. Janet Pope: TB Testing and TNF Inhibitors | |
| 21 Aug 2018 | Social | TB Study of 550 RA, PsA, AS patients on TNF inhibitors from Romania (population risk is 97 per100k PY): incidence of TB on TNFi to be 1348.0, 862.1 and 540.2 per 100k Pt-Yrs (measured as TST >5, TST>10mm, QFT) https://t.co/SIkefJg909 | |
| 03 Aug 2018 | News | Higher Infection Rates for Infliximab in Psoriasis | |
| 19 Jul 2018 | News | Biomarker Combo Predicts TNF Inhibitor Responses | |
| 12 Jun 2018 | News | TNF Inhibitors Don't Increase Cancer Risk in Children | |
| 11 Jun 2018 | News | Risk of Psoriasis Complicating TNF Inhibitor Therapy | |
| 09 Apr 2018 | News | Favorable Certolizumab Safety Profile in Pregnancy | |
| 05 Mar 2018 | News | Severe Stevens-Johnson and Toxic Epidermal Necrolysis Syndromes May Respond to Etanercept | |
| 20 Feb 2018 | News | Pediatric Use of TNF inhbitors Does Not Increase Malignancy Risk | |
| 20 Feb 2018 | Social | PANTS study:Personalized anti-TNF Therapy in Crohn Disease tests real-world eficacy, safety & immunogenicity of infliximab vs biosimilar CT- P13 vs adalimumab. Wk 54 remission rate was 40% INFX, 40% CTP13 & 34% in ADA; immunogenicity was 26%, 28%, 11% https://t.co/irhImH6ipP |
